Looking to sell Paradromics stock or options?
Paradromics develops data-rate brain-computer interface technology aimed at enhancing data transmission rates between the human brain and machines. This technology provides high-volume, bidirectional data streaming between brains and computers, allowing patients with neurological disorders to overcome deficits in biological connectivity.
Capital Factory, Julien Nguyen, Wescott Capital, Deepwater Asset Management, Pureland Group, Dolby Family Ventures, Arjun Bansal, 2050 Capital, Stelac Capital Partners, FJ Labs, Primavera Venture Partners, What If Ventures, Wealthing VC Club, Prime Movers Lab, ATEL Capital Group, Westcott, 15th Rock, Wormhole Capital, Kaitai Capital, Bluebirds Capital, Cloudstone Capital, Explorer Equity Group, Synergy Ventures, Jun Deng, Harmonix Fund.
Paradromics is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Paradromics stock. Depending on Paradromics’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Paradromics stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Paradromics stock in two ways. First, Paradromics employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Paradromics stock. Note that all transactions in Paradromics shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Paradromics stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Paradromics stock. Typically, shares of private companies like Paradromics are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On May 2023, Paradromics is reported to have closed an equity financing in which the investors valued the company at $409M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Paradromics shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Paradromics is not currently publicly traded, it does not have a ticker symbol.
Paradromics has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Paradromics is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Paradromics shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.